BD Pharmingen, Horizon and Phosflow 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 BD 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2017-03-09
  • 사례 출판 날짜
    2017-03-09
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: bd pharmingen, horizon and phosflow medical device manufacturer, bd, has issued a medical device safety alert concerning its products: bd pharmingen [product format: alexa fluor 700, apc-cy 7, apc-h7, pe-cy 5], bd horizon [product format: apc-r700, buv661, bv605, bv650, bv711, bv786, pe-cf594] and bd phosflow [product format: alexa fluor 700]. the manufacturer has observed an increase in the number of complaints of low or no signal, or lot-to-lot variability in signal for single vial reagents with fluorophores. in some cases, users observed vial-to-vial variability in signal within the same lot. based on internal investigations, the manufacturer has identified specific lots of the above product formats, shipped between 16 may 2016 and 10 february 2017, that are being recalled. the manufacturer has launched a thorough investigation to identify root cause for the sporadic degradation of the reagents. at this time, all data suggest that a significant change in the lighting conditions at an alternate warehouse location is the primary contributor of the low to no signal in the product. based on the investigation, the current storage requirement on the product labeling, “store undiluted at 4°c and protected from prolonged exposure to light,” is sufficient to protect the product from degradation. according to the manufacturer, the potential degradation of product may result in a false identification of cell populations and/or aberrant staining patterns. the manufacturer advises users to take the following actions: either discard any remaining inventory and request a replacement or perform quality control using biological cells per their standard protocol on each vial of reagent just prior to use to confirm that the reagent is still performing as intended; and review any data that may have been generated from the affected product list. according to the local supplier, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 9 march 2017.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: BD Pharmingen, Horizon and Phosflow
  • Manufacturer
    BD

Manufacturer

BD